戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 alysis confirmed AP-2alpha variants in ovine chorionic binucleate cell nuclear extracts, one of which
2      DNase I protection analysis using ovine chorionic binucleate cell nuclear protein, identified 19
3 ormone/prolactin gene family, is produced by chorionic binucleate cells at the maternal-fetal interfa
4 ent transactivation of the oPL gene in ovine chorionic binucleate cells.
5 al membranes, is expressed by leukocytes and chorionic cytotrophoblast cells.
6 eak extra-embryonic ectoderm and late-streak chorionic ectoderm - were microdissected into fractions
7 f the ectoplacental cavity via union between chorionic ectoderm and the ectoplacental cone, a decline
8 ning proliferation throughout the developing chorionic ectoderm and, thus, in supporting its stem cel
9  cone, a decline in the frequency of mitotic chorionic ectoderm cells in vivo, and of trophoblast ste
10 ential increased steadily in extra-embryonic/chorionic ectoderm until the first somite pairs formed,
11 e distributed throughout the extra-embryonic/chorionic ectoderm, an observation that is probably attr
12             AP-2alpha was localized in ovine chorionic epithelial cells by immunohistochemistry and a
13 e, we propose that the presence of placental chorionic fusion and the exchange of cell lines between
14 othesize that IL-22 cytokine produced by the chorionic girdle binds IL-22R1 on endometrium, serving a
15 triking increase in IL-22 mRNA expression in chorionic girdle from days 32 to 35 and an absence of IL
16                Our discovery of IL-22 in the chorionic girdle is a novel finding, as this cytokine ha
17 ation of mRNA encoding the cytokine IL-22 in chorionic girdle relative to noninvasive chorion.
18 e used to verify high expression of IL-22 in chorionic girdle.
19 experiments showed that treatment with human chorionic gonadatropin (hCG) prevented death and the exp
20 o regulate expression of the placental human chorionic gonado-tropin (hCG) alpha- and beta-subunit ge
21 ermine the modulation of uterine function by chorionic gonadotrophin (CG) in a nonhuman primate.
22 MP4-treated cells form syncytia that express chorionic gonadotrophin (CG).
23 mor marker alpha-fetoprotein (AFP) and human chorionic gonadotrophin (HCG) during the first two cycle
24                                        Human chorionic gonadotrophin (hCG) is largely used to confirm
25 onths of trying to conceive or until a human chorionic gonadotrophin (hCG) test confirmed pregnancy.
26 hich encode alpha and beta subunits of human chorionic gonadotrophin (hCG), a hormone essential to mo
27 s) of interactions between an antigen, human chorionic gonadotrophin (hCG), and antibodies, anti-alph
28 of mouse cell line-derived recombinant human chorionic gonadotrophin (r-alpha hCG), a protein that is
29  expression of differentiation markers human chorionic gonadotrophin and placental alkaline phosphata
30 placental (i.e., her offspring's) homologous chorionic gonadotrophin beta5 (CGB5) and CSH1 genes and
31             Using primers specific for human chorionic gonadotrophin gene, the presence of human DNA
32 tion provided by alpha-fetoprotein and human chorionic gonadotrophin in the management of germ cell t
33  microg/L; Ca-125 level, 15 U/mL; beta-human chorionic gonadotrophin level < 2 IU/mL).
34             The importance of accurate human chorionic gonadotrophin monitoring and the types of huma
35 adotrophin monitoring and the types of human chorionic gonadotrophin produced in cancer are also topi
36 nant purified beta-arrestin-1 mimicked human chorionic gonadotrophin to promote desensitization of hu
37 um tumor markers alpha-fetoprotein and human chorionic gonadotrophin were correlated with treatment o
38 rker decline (alpha-fetoprotein and/or human chorionic gonadotrophin) during the first two cycles of
39 nce of a variety of sequences, such as human chorionic gonadotrophin, ubiquitin, TFIIA, guanine nucle
40 otrophin to promote desensitization of human chorionic gonadotrophin-stimulated AC activity, in the p
41  of prior therapy (P < .001), baseline human chorionic gonadotropin > or = 1,000 U/L (P = .01), and l
42 ease at the time of GCT diagnosis, and human chorionic gonadotropin >/= 1,000 mIU/mL at initiation of
43 istration of exogenous testosterone or human chorionic gonadotropin (an LH receptor agonist), respect
44 that predicts pregnancy using the beta human chorionic gonadotropin (b-hCG) test from both the morpho
45           The rate of HBsAg in 6,976 B-human chorionic gonadotropin (B-hCG)-positive specimens, as de
46 iocarcinoma that was confirmed by beta human chorionic gonadotropin (beta-HCG) levels and histopathol
47 ssed for four mRNA tumor markers: beta-human chorionic gonadotropin (beta-hCG), oncogene receptor (c-
48 serum alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin (betaHCG) levels were 483 ng/mL a
49 s, which include the placental hormone human chorionic gonadotropin (CG) and the anterior pituitary h
50 rly pregnancy by the placental production of chorionic gonadotropin (CG) but regresses in the presenc
51 pressing either the luteinizing hormone (LH)/chorionic gonadotropin (CG) or follicle-stimulating horm
52 LH), follicle-stimulating hormone (FSH), and chorionic gonadotropin (CG), are cysteine-knot growth-fa
53              The human glycoprotein hormones chorionic gonadotropin (CG), thyrotropin (TSH), lutropin
54 h the production of the glycoprotein hormone chorionic gonadotropin (CG), which is secreted into the
55   Following induction of ovulation by equine chorionic gonadotropin (eCG)/human CG (hCG) treatment an
56 ere alpha-fetoprotein (AFP) 2.0 ng/mL, human chorionic gonadotropin (hCG) 151,111 IU/L, and lactate d
57                           In contrast, human chorionic gonadotropin (hCG) and other glycoprotein horm
58 noassays for two model cancer markers, human chorionic gonadotropin (hCG) and prostate specific antig
59    Human luteinizing hormone (hLH) and human chorionic gonadotropin (hCG) are human glycoprotein horm
60                                  Using human chorionic gonadotropin (hCG) as a model analyte to descr
61 ity, which has been demonstrated using human chorionic gonadotropin (hCG) as an example.
62 PFF-NPFFR2 on expression of syncytial [human chorionic gonadotropin (hCG) beta] and fusogenic [syncyt
63                                        Human chorionic gonadotropin (hCG) binds to the exodomain, and
64                                        Human chorionic gonadotropin (hCG) binds to the extracellular
65                                  Serum human chorionic gonadotropin (hCG) concentration was 200 mIU/m
66 l trophoblastic disease include raised human chorionic gonadotropin (hCG) concentrations 6 months aft
67 we proposed that the pregnancy hormone human chorionic gonadotropin (hCG) efficiently attracts human
68 questioned whether women with PMs need human chorionic gonadotropin (hCG) follow-up.
69                                        Human chorionic gonadotropin (hCG) has been shown to reduce th
70                         Treatment with human chorionic gonadotropin (HCG) increased levels of plasma
71                                        Human chorionic gonadotropin (hCG) induces de novo synthesis o
72                 We show that human embryonic chorionic gonadotropin (hCG) induces sequential mRNA exp
73 n immune-compromised mice that secrete human chorionic gonadotropin (hCG) into the host mouse and inc
74                                        Human chorionic gonadotropin (hCG) is a glycoprotein hormone e
75                                        Human chorionic gonadotropin (hCG) is a glycoprotein secreted
76                                        Human chorionic gonadotropin (hCG) is a heterodimeric member o
77                                        Human chorionic gonadotropin (hCG) is an important biomarker f
78                                        Human chorionic gonadotropin (hCG) is necessary for the mainte
79                                        Human chorionic gonadotropin (hCG) is one of the earliest horm
80 tudies do not establish a single serum human chorionic gonadotropin (hCG) level that is diagnostic of
81 g/kg intravenously every 2 weeks until human chorionic gonadotropin (hCG) normalization, followed by
82                          The impact of human chorionic gonadotropin (hCG) on prostate carcinoma viabi
83                                        Human chorionic gonadotropin (hCG) preparations contain activi
84            Recent clinical trials with human chorionic gonadotropin (hCG) prepared from early pregnan
85                                        Human chorionic gonadotropin (hCG) promotes proliferation of e
86 sitivity, affinity and specificity for human chorionic gonadotropin (hCG) protein.
87                                    The human chorionic gonadotropin (hCG) proteins constitute a diver
88                 Treatment of mice with human chorionic gonadotropin (hCG) resulted in increased circu
89                            The hormone human chorionic gonadotropin (hCG) serves to maintain the fetu
90                                        Human chorionic gonadotropin (hCG) suppresses cell-mediated al
91  on the basis of persistently positive human chorionic gonadotropin (hCG) test results in the absence
92                              We detect human chorionic gonadotropin (hCG) using an antibody-based san
93 TH gene transcription is stimulated by human chorionic gonadotropin (hCG) via cyclic AMP-induced andr
94  resistance to EMA/CO, and because the human chorionic gonadotropin (hCG) was near normal, they were
95                    In the present work human chorionic gonadotropin (hCG) was used as a model protein
96  rat breast cancer model indicate that human chorionic gonadotropin (hCG), a hormone that is present
97 Experimental observations suggest that human chorionic gonadotropin (hCG), a major hormone of pregnan
98 Results of recent studies suggest that human chorionic gonadotropin (HCG), a placental glycoprotein h
99 rs, human C-reactive protein (CRP) and human chorionic gonadotropin (hCG), by using fluorescent-label
100 e mechanisms of the human pregnancy hormone, chorionic gonadotropin (hCG), in the liver.
101  express a surface feature that mimics human chorionic gonadotropin (hCG), the cognate ligand for LHr
102 pha-fetoprotein, unconjugated estriol, human chorionic gonadotropin (hCG), the free beta subunit of h
103 rthermore, using the mediator molecule human chorionic gonadotropin (hCG), we interface the intracell
104 zes the peptide GVLPALPQV derived from human chorionic gonadotropin (hCG)-beta.
105 f normal, 8.0 ug/L), and a normal beta-human chorionic gonadotropin (HCG).
106 f the conceptus during implantation is human chorionic gonadotropin (hCG).
107 the common performance enhancing drug, human chorionic gonadotropin (hCG).
108  verified for the efficient binding of Human Chorionic Gonadotropin (hCG).
109 oma cells before and after exposure to human chorionic gonadotropin (hCG).
110 wo antigen/antibody pairs were investigated: chorionic gonadotropin (hCG)/mouse monoclonal anti-hCG a
111 y constrained than the beta-subunit of human chorionic gonadotropin (hCG-beta).
112 lactate dehydrogenase (LDH; .0001) and human chorionic gonadotropin (HCG; .0001).
113  and the intracellular beta subunit of human chorionic gonadotropin (hCGbeta) and peroxisome prolifer
114 t with induction of aromatase (hCYP19A1) and chorionic gonadotropin (hCGbeta) expression.
115  Activation of the luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor (LHR) in cultur
116  the regulation of luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor mRNA stability
117                The luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor, which belongs
118 eta-subunit of macaque (Macaca fascicularis) chorionic gonadotropin (mCG-beta) is more conformational
119  increased alpha fetoprotein (n = 18), human chorionic gonadotropin (n = 5), or both (n = 2); nine ha
120 hree markers (alpha-fetoprotein [AFP], human chorionic gonadotropin [hCG], and lactate dehydrogenase
121 eleasing hormone analogs [n = 38 653], human chorionic gonadotropin [n = 68 181], progesterone [n = 4
122       Loss of LSD1 also impairs induction of chorionic gonadotropin alpha (CGA) and chorionic gonadot
123 the gonadotropin hormone alpha-subunit gene, chorionic gonadotropin alpha (Cga), is responsible for C
124 nt mare serum gonadotropin followed by human chorionic gonadotropin also stimulated cumulus expansion
125 n an increased blood level of the beta human chorionic gonadotropin and a histopathological examinati
126  day on days 1, 8, and 15]), patients' human chorionic gonadotropin and alfa-fetoprotein concentratio
127  Patients with a favourable decline in human chorionic gonadotropin and alfa-fetoprotein continued BE
128  be induced by two placental hormones: human chorionic gonadotropin and human chorionic somatotropin
129 ignificantly, directly associated with human chorionic gonadotropin and inversely with estrone-3-gluc
130    Increased leptin levels, as well as human chorionic gonadotropin and luteinizing hormone receptors
131 two maternal serum hormones, free beta-human chorionic gonadotropin and pregnancy-associated plasma p
132 rnal age, maternal levels of free beta human chorionic gonadotropin and pregnancy-associated plasma p
133 rnal age, maternal levels of free beta human chorionic gonadotropin and pregnancy-associated plasma p
134 cessful (91 percent), the mean (+/-SD) serum chorionic gonadotropin and progesterone concentrations w
135 y, biochemically (by the production of human chorionic gonadotropin and progesterone), and immunohist
136   Pretreatment serum concentrations of human chorionic gonadotropin and progesterone, the size and vo
137 ing levels of the free beta subunit of human chorionic gonadotropin and stillbirth risk.
138 ted protein domains (F(c)) of two anti-human chorionic gonadotropin antibodies were proteolytically r
139 ody-antigen immune reaction by binding human chorionic gonadotropin antigen to immunoglobulin antibod
140 H), luteotropin (LH), follitropin (FSH), and chorionic gonadotropin are members of the heterodimeric
141                        Measurements of serum chorionic gonadotropin are of little clinical value for
142  alpha-fetoprotein and beta-subunit of human chorionic gonadotropin are used as biomarkers for the ma
143 nt of effective treatments, the use of human chorionic gonadotropin as a biomarker, and centralisatio
144 firm the primary site and the level of human chorionic gonadotropin as independent factors.
145 [PAPP-A], and the free beta subunit of human chorionic gonadotropin at 10 weeks 3 days through 13 wee
146 on of chorionic gonadotropin alpha (CGA) and chorionic gonadotropin beta (CGB) genes, which encode al
147 nizes the GVL peptide (GVLPALPQV) from human chorionic gonadotropin beta presented by the peptide-HLA
148  urothelial carcinoma-associated 1 and human chorionic gonadotropin beta type II genes.
149 ellular kinetic folding pathway of the human chorionic gonadotropin beta-subunit (hCG-beta) reveals t
150 ity to secretion and assembly with the human chorionic gonadotropin beta-subunit (hCG-beta).
151 ons of trophoblast cells that produce equine chorionic gonadotropin between days 40 and 120 of normal
152                             The secretion of chorionic gonadotropin by TSC-derived ST reflects a repr
153 treatment with a desensitizing dose of human chorionic gonadotropin caused transcriptional down-regul
154 with tubal ectopic pregnancies, a high serum chorionic gonadotropin concentration is the most importa
155 ion analysis revealed the pretreatment serum chorionic gonadotropin concentration to be the only fact
156   There was no relation between higher serum chorionic gonadotropin concentrations and the risk of ge
157                                 Higher serum chorionic gonadotropin concentrations were associated wi
158                                 Higher serum chorionic gonadotropin concentrations were associated wi
159 tant receptors and is dependent on the human chorionic gonadotropin dose, the surface concentration o
160  pre-mRNA encoding the beta-subunit of human chorionic gonadotropin gene 6 and pre-trans-splicing mol
161 CSF levels of alpha-fetoprotein or betahuman chorionic gonadotropin had normalization with chemothera
162 onography and sensitive tests for beta-human chorionic gonadotropin have evolved, the presentation of
163 s and real immunorecognition assays of human chorionic gonadotropin hormone are well below the visual
164 include genes located in the promoter of two chorionic gonadotropin hormone genes.
165 mplantation was defined by the appearance of chorionic gonadotropin in maternal urine.
166 e in three, alpha-fetoprotein and beta human chorionic gonadotropin in one) suffered a relapse, compa
167                   Synthesis and secretion of chorionic gonadotropin in trophoblast cells of the place
168                                        Human chorionic gonadotropin increased GRTH gene expression an
169                                              Chorionic gonadotropin is a heterodimeric glycoprotein h
170                               Maternal serum chorionic gonadotropin is measured to screen for fetal c
171 l/L]), and serum alpha-fetoprotein and human chorionic gonadotropin levels were normal.
172 rum and CSF alpha-fetoprotein and beta-human chorionic gonadotropin levels were not associated with P
173 d six weeks or more, the first appearance of chorionic gonadotropin occurred 6 to 12 days after ovula
174 stillbirth (odds ratio for every increase in chorionic gonadotropin of 1 multiple of the median, 1.4;
175 oprotein of 100 ng/mL or greater or of human chorionic gonadotropin of 5,000 U/L or greater (group B)
176 cal evidence and highly elevated serum human chorionic gonadotropin or alfa-fetoprotein concentration
177 ts expression is increased 2.5-fold by human chorionic gonadotropin over a 12-h period.
178         Treatment of Leydig cells with human chorionic gonadotropin rapidly induced free radical, PBR
179 helix (TM3) of the luteinizing hormone/human chorionic gonadotropin receptor (LH/hCGR) in regulating
180                The luteinizing hormone/human chorionic gonadotropin receptor (LH/hCGR) undergoes palm
181 ly as an agonist for the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) and suggested to
182                      The luteinizing hormone chorionic gonadotropin receptor (LHCGR) is a G(s)-couple
183 alized expression of the luteinizing hormone/chorionic gonadotropin receptor, PROK1, PROKR1, and LIF
184 assay) was inhibited by 57 %, and both human chorionic gonadotropin secretion and L-leucine influx th
185 ed CTBs in low oxygen leads to reduced human chorionic gonadotropin secretion and STB-associated gene
186                                              Chorionic gonadotropin secretion was > 4000-fold higher
187 h WT mice by both in vivo and in vitro human chorionic gonadotropin stimulation.
188 e was defined as a negative serum beta-human chorionic gonadotropin test (beta-hCG < 6 IU/L) 17 days
189 eriod, and a combination of a positive human chorionic gonadotropin test and an outpatient obstetric
190 l pregnancy defined by a positive beta human chorionic gonadotropin test, two weeks after inseminatio
191  of a pregnancy outcome was a positive human chorionic gonadotropin test; least predictive was an obs
192  acts independently or additively with human chorionic gonadotropin to enhance androstenedione secret
193 pply this platform to the detection of human chorionic gonadotropin using surface plasmon resonance.
194 of the risk of an adverse outcome than serum chorionic gonadotropin values.
195    GRTH is transcriptionally up-regulated by chorionic gonadotropin via cyclic AMP-induced androgen f
196 pecimens for up to 1 year, and urinary human chorionic gonadotropin was assayed to detect conception
197                          Daily urinary human chorionic gonadotropin was assayed to detect conception
198 al records of 28,743 girls and women in whom chorionic gonadotropin was measured during the second tr
199       Using purified plasma membranes, human chorionic gonadotropin was similarly observed to have no
200 istologic subtype and increase of beta-human chorionic gonadotropin were not significantly correlated
201                          For anti-hCG (human chorionic gonadotropin) mAb 8F11, studied at two incorpo
202 f tumor markers (alpha fetoprotein and human chorionic gonadotropin), and imaging.
203 n harbors positional candidate genes such as chorionic gonadotropin, alpha chain; collagen, type XIX,
204 evels were compared with those of beta-human chorionic gonadotropin, alpha-fetoprotein, and lactate d
205                      Thyroid function, human chorionic gonadotropin, and estradiol were measured befo
206 -linked sugar chains found in fetuin, equine chorionic gonadotropin, and glycophorin can be analyzed
207                alpha-Fetoprotein, beta-human chorionic gonadotropin, and lactate dehydrogenase had se
208 pregnancy, serum concentration of beta-human chorionic gonadotropin, and stage of disease, with both
209 ic glycoprotein substrates by agalacto human chorionic gonadotropin, comprising 29 nM for beta4GalNAc
210 , cortisol, and reproductive hormones (human chorionic gonadotropin, estradiol, progesterone, human p
211 urine samples were collected to assess human chorionic gonadotropin, estrone-3-glucuronide, and pregn
212 detection of three markers: beta-chain human chorionic gonadotropin, hepatocyte growth factor recepto
213  of a set of three fertility hormones: human chorionic gonadotropin, human luteinizing hormone, and f
214 pharmacologically rescued by exogenous human chorionic gonadotropin, indicating that LH-responsivenes
215 used to bind the glycoprotein hormone, human chorionic gonadotropin, produced during normal pregnancy
216 ver time, produce extensive amounts of human chorionic gonadotropin, progesterone, placental growth f
217 n a modified commercial strip test for human chorionic gonadotropin, the hormone used to detect pregn
218 easurement of alpha-fetoprotein, total human chorionic gonadotropin, unconjugated estriol, and inhibi
219 ered hCG-SNAP fusion reporter protein (human chorionic gonadotropin-O(6) -alkylguanine-DNA alkyltrans
220                                    The human chorionic gonadotropin-stimulated phosphorylation of ERK
221 ociated with the beta-core fraction of human chorionic gonadotropin.
222 ly levels of estrone-3-glucuronide and human chorionic gonadotropin.
223 the day of induction of ovulation with human chorionic gonadotropin.
224 d ovulation with a single injection of human chorionic gonadotropin.
225 ein hormone alpha subunit gene, a subunit of chorionic gonadotropin.
226 rogen and progesterone metabolites and human chorionic gonadotropin.
227  by high circulating concentrations of human chorionic gonadotropin.
228 ndant in the serum and ovaries of beta-human chorionic growth hormone-stimulated frogs.
229 occurs fully when the embryos hatch from the chorionic membrane and encounter normal oxidative stress
230 imary HLA-G+ EVT from the placental disk and chorionic membrane from healthy term pregnancy.
231 rom the endometrial stalk (maternal side) to chorionic plate (fetal side).
232                                              Chorionic plate and myometrial artery relaxation was inc
233                                              Chorionic plate arteries from full-term placentas and sp
234 genitors of fetal origin were present in the chorionic plate of the placenta before the onset of feto
235 al expression and that inflammatory cells in chorionic plate or umbilical cord blood vessel walls be
236        Adequate blood flow through placental chorionic plate resistance arteries (CPAs) is necessary
237 ly expressed in ectoplacental cone cells and chorionic plate, and later in the labyrinthine trophobla
238 itor tissue of the umbilical cord), with the chorionic plate.
239 ired for normal organization of cells in the chorionic plate.
240                                        Human chorionic somatomammotropin (CS) and placental growth ho
241 ropes, whereas the remaining four genes, the chorionic somatomammotropin genes (hCS-L, hCS-A, and hCS
242 , mammalian muscle-specific genes, and human chorionic somatomammotropin genes.
243 ones: human chorionic gonadotropin and human chorionic somatotropin hormone (CSH) produced by the pla
244  are crucial for development of the anterior chorionic structures.
245 chorionic trophoblast cells, including basal chorionic trophoblast (BCT) cells located at the chorioa
246 transcription factor, is highly expressed in chorionic trophoblast cells, including basal chorionic t
247 s led to a complete loss of undifferentiated chorionic trophoblasts after embryonic day 9.5 and preve
248 sement membranes located at the interface of chorionic trophoblasts and allantoic mesoderm.
249  embryos, however, restored the integrity of chorionic trophoblasts and enabled placental labyrinth f
250 ngly, Arnt-null TS cells differentiated into chorionic trophoblasts and syncytiotrophoblasts, as demo
251 ected in the placental syncytiotrophoblasts, chorionic trophoblasts, decidual cells, and amniotic epi
252  and HAI-1 were expressed in a population of chorionic trophoblasts.
253 V spreads from basal and parietal decidua to chorionic villi and amniochorionic membranes and that ta
254 al cells, fibroblasts, and Hofbauer cells in chorionic villi and amniotic epithelial cells and tropho
255                 An increase in the number of chorionic villi and blood vessels over that in controls
256 tly contacts syncytiotrophoblasts that cover chorionic villi and cytotrophoblasts that invade uterine
257  differentiated syncytiotrophoblast (STB) in chorionic villi and extravillous trophoblast (EVT) at th
258 low) and CD34(+)CD45(low)-that were found in chorionic villi and in the chorioamniotic membrane.
259  this hypothesis, we exposed first-trimester chorionic villi and isolated cytotrophoblasts to CMV in
260 und in trophoblasts and endothelial cells of chorionic villi and uterine arteries.
261 es, and inflammatory infiltrate in placental chorionic villi are associated with adverse pregnancy re
262 GF during explant culture of first-trimester chorionic villi enhanced extravillous trophoblast differ
263                   Antigens were also seen in chorionic villi of one of the first trimester placentas.
264 alivary glands, uterine decidua, and injured chorionic villi of the placenta, demonstrating both its
265 s present in the syncytiotrophoblasts of the chorionic villi of the rhesus placenta, within villous c
266 either into syncytiotrophoblasts in floating chorionic villi or extravillous trophoblasts (EVTs) at t
267 vering trophoblastic lacunae or newly formed chorionic villi remained largely Mamu-AG-negative.
268                                           In chorionic villi that were infected with CMV in utero, sy
269           DNA methylation in first-trimester chorionic villi was assessed in chromosomally normal mis
270  placentas and explants from first-trimester chorionic villi with the prototype Ugandan and a recentl
271 on of glycosaminoglycans on trophoblasts and chorionic villi, resulting in increased permeability of
272                                           In chorionic villi, syncytiotrophoblasts did not become inf
273 yncytiotrophoblasts and cytotrophoblasts, in chorionic villi-in clinical cases of congenital infectio
274  which give rise to the mature cell types of chorionic villi-syncytiotrophoblasts on the surfaces of
275 lasts, infect underlying cytotrophoblasts in chorionic villi.
276 es from cultured lymphocytes, amniocytes, or chorionic villi.
277 vitro culture of explants of human placental chorionic villi.
278 dition, using organotypic human midgestation chorionic villous explants, we show that syncytiotrophob
279 ophan has been studied using human placental chorionic villous explants.
280                           Microarray data of chorionic villous samples (CVSs) obtained from women of
281 , in response to low oxygen, first trimester chorionic villous tissue from pregnancies at increased r
282  cells and in the trophoblast layer of human chorionic villus but not in a gonadotrope cell line that
283                   One case of mosaicism in a chorionic villus sample, and two cases indicating somati
284  sector submitted data for amniotic fluid or chorionic villus samples referred from April, 1999, to M
285            Of 34,995 amniotic fluid and 3049 chorionic villus samples that had karyotyping and a rapi
286  amniotic fluid samples and 152 (45%) of 327 chorionic villus samples were associated with a substant
287             1148 amniotic fluid samples, 188 chorionic villus samples, and 37 fetal tissue samples we
288         Of 119,528 amniotic fluid and 23,077 chorionic villus samples, rapid aneuploidy testing repla
289  foetus diagnosed with del(4)(q33) following chorionic villus sampling (CVS) at 14 weeks, and the pre
290 concordant with available clinical data from chorionic villus sampling (CVS) or amniocentesis procedu
291            We did a cost-utility analysis of chorionic villus sampling and amniocentesis versus no in
292 e of predisposing gene mutation according to chorionic villus sampling and testing of the neonate's b
293  of fetal cells obtained by amniocentesis or chorionic villus sampling is the current standard for pr
294  use of the cells from the amniotic fluid or chorionic villus sampling that are used for prenatal dia
295 idelines recommend offering amniocentesis or chorionic villus sampling to women aged 35 years or olde
296 d-old embryos, (ii) induced abortions, (iii) chorionic villus sampling, (iv) amniocentesis, and (v) f
297 00) were offered diagnostic amniocentesis or chorionic villus sampling.
298 ages (Hofbauer cells) that reside within the chorionic villus stroma.
299          We have established early-gestation chorionic villus-derived placenta mesenchymal stromal ce
300 o came to 16 prenatal diagnostic centers for chorionic-villus sampling or early amniocentesis at 9 to

 
Page Top